Skip to main content
Search results
https://www.fda.gov/media/181850/download
about 1 year ago -
...increase of systemic exposure of atazanavir or darunavir (once daily dosing regimen)...least 35 kg co-administered with atazanavir or weighing at ...
https://www.fda.gov/media/181671/download
about 1 year ago -
...increase of systemic exposure of atazanavir or darunavir (once daily dosing regimen)...least 35 kg co-administered with atazanavir or weighing at ...
https://www.fda.gov/drugs/hiv-treatment/hiv-treatment-information-pregnant-women
3 months ago -
Human Data Epzicom Label Evotaz* atazanavir 300 mg cobicistat 150 mg Fixed Dose...Human Data Prezista Label Reyataz* atazanavir sulfate 150 mg, 200 ...
https://www.fda.gov/drugs/drug-safety-and-availability/comunicado-de-la-fda-sobre-la-seguridad-de-los-medicamentos-importantes-interacciones-entre-el
almost 4 years ago -
...(VIH) reforzados con ritonavir (atazanavir, lopinavir, darunavir) tiene el potencial...(VIH) reforzados con ritonavir (atazanavir, lopinavir ...
https://www.fda.gov/drugs/development-resources/reviews-pediatric-studies-conducted-under-bpca-and-pediatric-assessments-conducted-under-prea-2007
7 months ago -
...-51KB Statistical (PDF -800KB) BPCA Atazanavir - Reyataz Bristol-Myers Squibb Company...pharmacology (PDF -913 KB) None PREA Atazanavir - Reyataz ...
https://www.fda.gov/drugs/development-resources/reviews-pediatric-studies-conducted-under-bpca-and-pediatric-assessments-conducted-under-prea-2007?source=govdelivery...
7 months ago -
...-51KB Statistical (PDF -800KB) BPCA Atazanavir - Reyataz Bristol-Myers Squibb Company...pharmacology (PDF -913 KB) None PREA Atazanavir - Reyataz ...
https://www.fda.gov/media/181536/download
9 months ago -
Patients on Saquinavir/Ritonavir or Atazanavir/Ritonavir in Combination with Tenofovir...Fumarate/cobicistat vs. Ritonavir-boosted Atazanavir Plus ...
https://www.fda.gov/drugs/human-immunodeficiency-virus-hiv/fda-approved-product-labeling-prezcobix-and-evotaz-use-pediatric-patients
over 4 years ago -
...the product labeling for EVOTAZ (atazanavir/cobicistat) for pediatric subjects...the product labeling for EVOTAZ (atazanavir/cobicistat) for pediatric ...
https://www.fda.gov/media/142206/download
over 4 years ago -
...cobicistat Generic Name NDA 206353: Atazanavir and cobicistat NDA 205395: Prezcobix...weighing ≥40 kg and approval of atazanavir and cobicistat ...
https://www.fda.gov/media/184570/download
4 months ago -
N050724 INJECTABLE, LIPID COMPLEX ATAZANAVIR SULFATE N206352 POWDER ATROPINE;
https://www.fda.gov/media/142255/download
over 4 years ago -
...cobicistat Generic Name NDA 206353: Atazanavir and cobicistat NDA 205395: Prezcobix...weighing ≥40 kg and approval of atazanavir and cobicistat ...
https://www.fda.gov/media/147910/download
about 2 years ago -
HIV-1-Infected Volunteers (The ARDENT Study: Atazanavir, Raltegravir, or Darunavir, with...microbiome changes on antiretroviral (atazanavir ...
https://www.fda.gov/media/179453/download
almost 2 years ago -
N050724 INJECTABLE, LIPID COMPLEX ATAZANAVIR SULFATE N206352 POWDER ATROPINE;
https://www.fda.gov/media/182410/download
7 months ago -
...gov/media/107036/download Reyataz atazanavir 06/02/2014 8/4/17 https://www.fda...gov/media/107020/download Reyataz Oral Powder atazanavir 09/24/2015 ...
https://www.fda.gov/media/181814/download
about 1 year ago -
...(4, 5.2) • Coadministration with atazanavir or rifampin. (4) ---------------
https://www.fda.gov/media/181655/download
about 1 year ago -
...(4, 5.2) • Coadministration with atazanavir or rifampin. (4) ---------------
https://www.fda.gov/media/174934/download
almost 2 years ago -
N050724 INJECTABLE, LIPID COMPLEX ATAZANAVIR SULFATE N206352 POWDER ATROPINE;
https://www.fda.gov/media/92688/download
almost 10 years ago -
N021567 atazanavir reissue 1...N021567 atazanavir reissue 1 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health...needed pediatric information on ataz ...
https://www.fda.gov/media/92643/download
almost 10 years ago -
N021567 atazanavir written request...N021567 atazanavir written request IND 56,897 Bristol-Myers Squibb Company Attention:...IND 56,897 on June 7 ...
https://www.fda.gov/drugs/drug-interactions-labeling/healthcare-professionals-fdas-examples-drugs-interact-cyp-enzymes-and-transporter-systems
10 months ago -
...inhibitor armodafinil 3A4 weak inducer atazanavir and ritonavir OATP1B1; OATP1B3 inhibitor
